Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-02-25 @ 6:43 PM
Study NCT ID:
NCT00508651
Status:
TERMINATED
Last Update Posted:
2011-12-30
First Post:
2007-07-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MI-CP150
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Judith Falloon , MD
Old Organization:
MedImmune, LLC